Abiomed Announces Q3 FY 2016 Revenue of $85.8 Million, Up 38% Over Prior Year

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. SAP
7. CSX
8. LRCX
9. MRK
10. LVS

Go back to Abiomed Announces Q3 FY 2016 Revenue of $85.8 Million, Up 38% Over Prior Year

Piper Jaffray Raises Price Target as Abiomed's (ABMD) Results Fall In-line with Preliminary Release

February 5, 2016 9:02 AM EST

Piper Jaffray reiterated a Neutral rating on ABIOMED (NASDAQ: ABMD), and raised the price target to $90.00 (from $75.00), following the company's 3Q earnings report. Results included revenue of $85.8M, representing ~38% y/y growth. ABMD provided updated guidance and raised its FY16 expected revenues to at or slightly better than $326M up from... More